SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing extreme volatility driven by a massive, supply-constrained short squeeze that has captivated the trading community. Investors are actively debating whether this parabolic move is a sustained mechanical phenomenon controlled by major stakeholders or a high-risk bubble nearing an inevitable and violent exhaustion.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on high volume as investors react to management's comments on production scaling and deepening partnerships within the AI infrastructure ecosystem. The community is actively discussing a perceived 'short squeeze' while dismissing recent negative sentiment as tactical positioning, focusing instead on the company's transition from speculative tech to a scaling supplier.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing intense volatility and social media attention as traders debate whether its recent surge is a sustainable breakout driven by its role in AI data center power infrastructure or a speculative bubble destined for a reversal. The community remains sharply divided, with bulls pointing to the company's strategic partnerships and GaN technology advancements, while bears argue the valuation is detached from current revenue and profitability.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is capturing market attention as investors monitor its progress in autoimmune cell therapy, with the community closely tracking upcoming clinical data readouts and institutional activity. Discussions center on the company's competitive position in the CAR-T space, its cash runway, and high expectations for its pipeline's potential in treating conditions like Myasthenia Gravis and Stiff Person Syndrome.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors are intensely debating whether the semiconductor sector is currently in a historic blow-off top or a sustained rally, with many expressing frustration over the persistent daily declines in this inverse ETF despite sector volatility. The community is deeply divided between those capitulating on their positions due to extreme exhaustion and those aggressively averaging down, pinning their hopes on an impending earnings-driven market correction or a significant technical reversal.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of a polarizing debate as investors weigh significant long-term potential in the eVTOL sector against immediate frustrations regarding the lack of a piloted transition flight. While community members are hotly debating the company's technical progress, regulatory hurdles, and speculative partnerships, the stock remains a focal point for active trading as participants react to ongoing news cycles and market-wide volatility.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch is capturing attention as the community rallies around its unique passive income model, which automatically distributes Solana rewards to holders every six hours. Investors are actively discussing the project's resilience, recent technical developments, and the long-term utility of its reward-generating mechanism.

OpenGradient

OpenGradient is gaining significant momentum as investors rotate capital from other speculative assets, with the community actively highlighting its early-stage potential and high-volume trading activity.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as investors focus on an upcoming poster presentation of its CDK9 inhibitor, SLS009, at the American Association for Cancer Research (AACR) meeting. The community remains deeply divided, with bulls pointing to the drug's potency and potential acquisition value, while bears emphasize frustrations over trial timelines and skepticism regarding the company's historical performance.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is currently trending as the community actively discusses major updates to its ecosystem, including the SAFU fund's recent transition to Bitcoin reserves and ongoing debates regarding regulatory compliance and market volatility. Traders are closely monitoring technical support levels and broader exchange liquidity, while a vocal segment of the community remains focused on potential long-term price targets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

NWBO
Northwest Biotherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NWBO News

NWBONorthwest Biotherapeutics Inc